Charmacy Pharmaceutical Co., Ltd. (HKG:2289)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.82
+0.01 (0.17%)
Apr 8, 2026, 3:46 PM HKT

Charmacy Pharmaceutical Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
46.2753.2851.3490.4723.15
Depreciation & Amortization
29.4532.1726.4730.6832.03
Other Amortization
6.323.852.952.891.73
Loss (Gain) From Sale of Assets
0.18-0.31-0.05-65.84-0.15
Asset Writedown & Restructuring Costs
-0.010.36-0.01-0.01
Loss (Gain) From Sale of Investments
--0.1--0
Provision & Write-off of Bad Debts
13.550.070.82.48-0.29
Other Operating Activities
51.0238.1441.1636.3141.71
Change in Accounts Receivable
69.57-409.63-98.17-222.47-54.81
Change in Inventory
-144.21116.04-193.35-77.7475.75
Change in Accounts Payable
202.76272.5472.25245.77-139.9
Operating Cash Flow
270.89106.04-96.5444.05-19.54
Operating Cash Flow Growth
155.47%----
Capital Expenditures
-7.47-15.73-40.85-8.59-25.04
Sale of Property, Plant & Equipment
0.380.0880.1980.350.64
Other Investing Activities
----0
Investing Cash Flow
-7.09-15.6439.3471.76-24.4
Short-Term Debt Issued
3,6703,6882,4922,8521,807
Long-Term Debt Issued
1,4611,266836.62.26974.03
Total Debt Issued
5,1314,9553,3292,8552,781
Short-Term Debt Repaid
-4,127-3,883-2,388-3,017-1,830
Long-Term Debt Repaid
-1,139-1,038-767.41-3.58-824.11
Total Debt Repaid
-5,266-4,921-3,156-3,021-2,654
Net Debt Issued (Repaid)
-135.3633.98172.72-166.48126.33
Common Dividends Paid
-80.5-64.2-75.5-28.44-52.49
Other Financing Activities
1.89-1.314.043.710.56
Financing Cash Flow
-213.98-31.54101.26-191.2174.4
Foreign Exchange Rate Adjustments
-0.010.010.010.03-
Net Cash Flow
49.8158.8744.07-75.3730.46
Free Cash Flow
263.4290.31-137.3935.46-44.58
Free Cash Flow Growth
191.69%----
Free Cash Flow Margin
6.01%2.04%-3.12%0.85%-1.18%
Free Cash Flow Per Share
2.440.84-1.270.33-0.41
Cash Income Tax Paid
51.7152.9858.8636.0237.42
Levered Free Cash Flow
-187.13-68.5510.27-145.91-28.06
Unlevered Free Cash Flow
-151.61-30.6436.48-123.99-2.12
Change in Working Capital
124.1-21.53-219.31-52.94-117.74
Source: S&P Global Market Intelligence. Standard template. Financial Sources.